OneMedNet reported Q1 2025 results showing a sharply modest revenue base of $0.137 million, with a substantial gross loss of $0.224 million and an operating loss of $2.224 million. Net income stood at a loss of $1.902 million, translating to an EPS of -$0.06. The quarter underscored persistent cash burn, with net cash used in operating activities of $1.948 million and free cash flow of $-1.953 million, while cash on hand remained only $0.144 million at period end. The balance sheet remains structurally fragile: total assets of $1.732 million versus liabilities of $18.282 million, and negative stockholders’ equity of $16.55 million. Deferred revenue of $0.503 million and substantial other current liabilities ($17.651 million) indicate limited near-term liquidity and a need for external financing to sustain operations unless revenue scale improves materially.
Key Performance Indicators
Revenue
Decreasing
137.00K
QoQ: 426.92% | YoY: -44.76%
Gross Profit
Decreasing
-224.00K
-1.64% margin
QoQ: -761.54% | YoY: -224.64%
Operating Income
Decreasing
-2.22M
QoQ: 16.58% | YoY: -5.85%
Net Income
Increasing
-1.90M
QoQ: 19.88% | YoY: 9.82%
EPS
Increasing
-0.06
QoQ: 57.14% | YoY: 33.33%
Revenue Trend
Margin Analysis
Financial Highlights
Revenue: Q1 2025 revenue $0.137 million; YoY change -44.8%; QoQ change +426.9%. Gross Profit: -$0.224 million; Gross Margin -1.64%; YoY margin decline -224.6%; QoQ -761.5%. Operating Income: -$2.224 million; Operating Margin -16.23%; YoY margin change -5.85%; QoQ +16.58%. Net Income: -$1.902 million; Net Margin -13.88%; YoY net income change +9.82%; QoQ +19.88%. Earnings per Share (EPS): -$0.06; YoY +33.33%; QoQ +57.14%. EBITDA: -$2.224 million; EBITDA Margin -16.23%. Cash Flow: Net cash from operating activities -$1.948 million; Capex -$0.005 million; Free cash flow -$1.953 million. Liquidity: Current ratio 0.0898; Quick ratio 0.0898; Cash ratio 0.0079. Asset efficiency: DSO 162.26 days; Asset Turnover 0.0791; Receivables Turnover 0.555. Leverage and valuation: Total liabilities $18.282 million; Total assets $1.732 million; Stockholders’ equity -$16.550 million; Price-to-sales ratio 134.42; Price-to-book ratio -1.113. Note: Peers data not available in provided material.
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
137.00K
-44.76%
426.92%
Gross Profit
-224.00K
-224.64%
-761.54%
Operating Income
-2.22M
-5.85%
16.58%
Net Income
-1.90M
9.82%
19.88%
EPS
-0.06
33.33%
57.14%
Key Financial Ratios
Gross Profit Margin
Weak
-1.64%
Gross profit margin is below industry norms, profitability concerns
Operating Profit Margin
Weak
-16.23%
Operating margin is below industry norms, profitability concerns
Net Profit Margin
Weak
-13.88%
Net profit margin is below industry norms, profitability concerns
Return on Assets
Weak
-1.10%
Return on assets suggests inefficient capital allocation
Return on Equity
Fair
11.50%
Return on equity is acceptable but below top-tier companies
Current Ratio
Concern
0.09
Current ratio below safe levels, potential liquidity risk
Debt to Equity
Conservative
-0.45
Debt-to-equity shows conservative leverage and low financial risk
P/E Ratio
Negative
-2.42x
Negative earnings make P/E ratio not meaningful
Price to Book
Undervalued
-1.11x
Trading below book value, potential value opportunity or distressed
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.
OneMedNet Corporation (ONMD) QQ4 2024 Financial Analysis: Revenue Decline, Persistent Losses, and Liquidity Challenges in Healthcare AI Imaging Data S...